Anti-PSMA chimeric antigen receptor T cell therapy (Adicet Bio)

N/A

Report date: 2024/03/07 11:52:36

Base Information

Drug NameAnti-PSMA chimeric antigen receptor T cell therapy (Adicet Bio)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-PSMA
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdicet Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdicet Bio Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A